Important recent findings add nuance: 2026 Cochrane analysis (22 trials, 1,995 participants): Intermittent fasting produced nearly identical weight loss and quality-of-life outcomes compared to conventional calorie-restricted dieting
More recently, due to the ongoing obesity epidemic and the better outcomes of the newer AOMs (i.e., GLP-1 medications), some plan sponsors are either choosing to add anti-obesity coverage in their pharmacy benefit or are at least considering doing so
Following the remodelling phase, a higher proportion of synthesised type I collagen, a corresponding decrease in cellularity, glycosaminoglycan content and type III collagen (Sharma and Maffulli 2005) can be observed
Br.J Clin Pharmacol 2007;64(3):335-345
Epidemiology Gamma-glutamyl transpeptidase deficiency is a very rare disease, which has been reported in seven patients in five families worldwide [3337]
[16] In more long standing cases, the severity of the condition often follows a relapsing and remitting course over time